JCR Pharmaceuticals Co (FRA:JCR) Institutional Ownership: 9.49% (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:JCR JCR Pharmaceuticals Co Ltd FRA:JCR
53 GF Score
Price €2.78
GF Value €3.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Institutional Ownership?

JCR Pharmaceuticals Co FRA:JCR -0.71% 53 Institutional Ownership is 9.49% as of Sep. 22, 2026. GuruFocus rates FRA:JCR with a GF Score™ of 53/100 and a GF Value™ of €3.87 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, JCR Pharmaceuticals Co's institutional ownership is 9.49%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, JCR Pharmaceuticals Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, JCR Pharmaceuticals Co's Float Percentage Of Total Shares Outstanding is 0.00%.

JCR Pharmaceuticals Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Institutional Ownership Chart

JCR Pharmaceuticals Co Historical Data

The historical data trend for JCR Pharmaceuticals Co can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 9.56 9.76 9.51 9.60 9.64 9.67 9.53 9.41 9.48 9.49
FRA:JCR
53GF Score
JCR Pharmaceuticals Co Ltd FRA:JCR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 9.49% mean?
JCR Pharmaceuticals Co (FRA:JCR) has a Institutional Ownership of 9.49% as of Sep. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Institutional Ownership too high?
JCR Pharmaceuticals Co's current Institutional Ownership is 9.49%. Overall, JCR Pharmaceuticals Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Institutional Ownership compare to LLY and JNJ?
JCR Pharmaceuticals Co's Institutional Ownership of 9.49% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Institutional Ownership is 9.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (FRA:JCR) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.87, compared to a current price of €2.78 — trading 28.2% below its estimated fair value. The current Institutional Ownership is 9.49%. JCR Pharmaceuticals Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For JCR Pharmaceuticals Co (FRA:JCR), the current Institutional Ownership is 9.49% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (FRA:JCR) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of €2.78 is trading 28.2% below its estimated GF Value™ of €3.87. GuruFocus considers JCR Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for FRA:JCR:

  • Institutional Ownership: 9.49%
  • GF Value™: €3.87 vs. price of €2.78 (28.2% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the FRA:JCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JCR Pharmaceuticals Co Business Description

Other Exchanges JCRRF:USA4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co., Ltd. is a Japanese specialty pharmaceutical company focused on biopharmaceuticals for rare and genetic diseases. Its core business is the research, development, manufacturing, and sale of recombinant protein and enzyme therapies, including enzyme replacement therapies for lysosomal storage disorders such as Fabry disease, mucopolysaccharidosis, and Pompe disease. The company also develops treatments for other unmet medical needs, including blood-brain barrier-penetrating biologics. JCR manufactures its products at its own facilities in Japan and sells primarily to hospitals, medical institutions, and healthcare providers, mainly in Japan, with expanding international operations through partnerships and licensing agreements. Revenue comes from pharmaceutical product sales, licensing and milestone payments, and contract manufacturing services. The company operates in a single reportable segment, the pharmaceutical business, and invests heavily in research and development.
53GF Score

Get the complete analysis for FRA:JCR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.78
Price
€3.87
GF Value